Electrolyte Abnormalities Associated With the Use of Atezolizumab – A Systematic Review
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Community Hospital Internal Medicine Perspectives"
DOI: 10.55729/2000-9666.1037
Abstract: Background and objectives In recent years, immune-checkpoint inhibitors (ICIs) particularly atezolizumab is on the rise in treating advanced malignancies. With its increased clinical use, various electrolyte abnormalities have been reported in the literature. In this… read more here.
Keywords: review; carcinoma; abnormalities associated; use atezolizumab ... See more keywords